
    
      -  Double-blind,randomized, multicenter

        -  Experiment duration: 14 days

        -  03 visits

        -  Evaluate the safety of an association with one anti-inflammatory and one
           gastroprotective compared to association with one anti-inflammatory and one
           gastroprotective agent in patients with acute or chronic osteoarticular inflammation

        -  Adverse events evaluation
    
  